Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Faze Medicines is a biotechnology company.
Catalio Capital Management has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Affini-T Therapeutics received $175.0M in a Series Unknown round. Catalio Capital Management's total known invested capital is $10.0B.
Catalio Capital Management's average investment size is $76.1M across its portfolio of 137 companies.
Recent Catalio Capital Management portfolio additions include Neumora Therapeutics, Clasp Therapeutics, NextPoint Therapeutics, Lassen Therapeutics, Centenara Labs. These companies were founded in 2020 or later.